X0206 3 2023-08-08 0 0001826457 Monte Rosa Therapeutics, Inc. GLUE 0001989401 Dunn Edmund MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900 BOSTON MA 02210 0 1 0 0 Principal Accounting Officer Common Stock 16761 D Stock Option (Right to Buy) 6.14 2031-04-11 Common Stock 14515 D Stock Option (Right to Buy) 13.41 2032-02-29 Common Stock 25700 D Stock Option (Right to Buy) 7.78 2033-01-02 Common Stock 35900 D Consists of restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of this option vested and became exercisable on March 17, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. 25% of this option vested and became exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. 25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Exhibit 24 - Power of Attorney /s/ Phil Nickson, Attorney-in-Fact 2023-08-18